<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910611-0135</DOCNO><DOCID>910611-0135.</DOCID><HL>   Technology:   IAF BioChem International Inc.</HL><DATE>06/11/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B4</SO><CO>   BCHXF T.BCH</CO><MS>TECHNOLOGY (TEC)</MS><IN>MEDICAL AND BIOTECHNOLOGY, GENETIC RESEARCH, PROSTHETICS (MTC)</IN><RE>CANADA (CN)NORTH AMERICA (NME)</RE><LP>   LAVAL, Quebec -- IAF BioChem International Inc. said itwill spend 40 million Canadian dollars (US$34.8 million) tobuild a vaccine production facility and a research anddevelopment center here.   The biotechnology and vaccine concern said the Quebec andCanadian governments are providing about half the financingfor the project in the form of grants and a loan guarantee.</LP><TEXT/></DOC>